NasdaqGS - Delayed Quote USD

Intuitive Surgical, Inc. (ISRG)

375.01 -2.07 (-0.55%)
At close: April 24 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,318,500.00
7,124,100.00
6,222,200.00
5,710,100.00
4,358,400.00
Cost of Revenue
2,456,600.00
2,394,600.00
2,026,200.00
1,751,600.00
1,497,200.00
Gross Profit
4,861,900.00
4,729,500.00
4,196,000.00
3,958,500.00
2,861,200.00
Operating Expense
3,013,300.00
2,962,700.00
2,618,900.00
2,137,500.00
1,811,400.00
Operating Income
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
Net Non Operating Interest Income Expense
227,000.00
192,100.00
29,700.00
69,300.00
157,200.00
Pretax Income
2,075,600.00
1,958,900.00
1,606,800.00
1,890,300.00
1,207,000.00
Tax Provision
71,700.00
141,600.00
262,400.00
162,200.00
140,200.00
Net Income Common Stockholders
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
Diluted NI Available to Com Stockholders
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
Basic EPS
5.65
--
3.72
4.79
3.02
Diluted EPS
5.54
--
3.65
4.66
2.94
Basic Average Shares
352,025.00
--
355,700.00
356,100.00
351,000.00
Diluted Average Shares
358,525.00
--
362,000.00
365,800.00
360,900.00
Total Operating Income as Reported
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
Total Expenses
5,469,900.00
5,357,300.00
4,645,100.00
3,889,100.00
3,308,600.00
Net Income from Continuing & Discontinued Operation
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
Normalized Income
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
Interest Income
--
192,100.00
29,700.00
69,300.00
157,200.00
Net Interest Income
227,000.00
192,100.00
29,700.00
69,300.00
157,200.00
EBIT
1,848,600.00
1,766,800.00
1,577,100.00
1,821,000.00
1,049,800.00
EBITDA
2,287,000.00
2,188,600.00
1,942,900.00
2,131,200.00
1,326,000.00
Reconciled Cost of Revenue
2,456,600.00
2,394,600.00
2,026,200.00
1,751,600.00
1,497,200.00
Reconciled Depreciation
438,400.00
421,800.00
365,800.00
310,200.00
276,200.00
Net Income from Continuing Operation Net Minority Interest
1,987,600.00
1,798,000.00
1,322,300.00
1,704,600.00
1,060,600.00
Normalized EBITDA
2,287,000.00
2,188,600.00
1,942,900.00
2,131,200.00
1,326,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 6/16/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RMD ResMed Inc.
183.78
-0.24%
 
RGEN Repligen Corporation
167.86
-2.00%
 
BDX Becton, Dickinson and Company
233.83
-0.23%
 
BNGO Bionano Genomics, Inc.
0.7611
-4.19%
 
WST West Pharmaceutical Services, Inc.
385.73
-1.15%
 
HOLX Hologic, Inc.
76.71
-0.62%
 
BAX Baxter International Inc.
40.93
-0.22%
 
STAA STAAR Surgical Company
47.82
-0.77%
 
NSTGQ NanoString Technologies, Inc.
0.3000
0.00%
 
BLCO Bausch + Lomb Corporation
14.90
+0.34%